Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology

Peter R. Carroll; J. Kellogg Parsons; Gerald Andriole; Robert R. Bahnson; Daniel A. Barocas; Erik P. Castle; William J. Catalona; Douglas M. Dahl; John W. Davis; Jonathan I. Epstein; Ruth B. Etzioni; Thomas Farrington; George P. Hemstreet; Mark H. Kawachi; Paul H. Lange; Kevin R. Loughlin; William Lowrance; Paul Maroni; James Mohler; Todd M. Morgan; Robert B. Nadler; Michael Poch; Chuck Scales; Terrence M. Shaneyfelt; Marc C. Smaldone; Geoffrey Sonn; Preston Sprenke; Andrew J. Vickers; Robert Wake; Dorothy A. Shead; Deborah Freedman-Cass

doi:10.6004/jnccn.2015.0181

Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology

Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Robert R. Bahnson, Daniel A. Barocas, Erik P. Castle, William J. Catalona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth B. Etzioni, Thomas Farrington, George P. Hemstreet, Mark H. Kawachi, Paul H. Lange, Kevin R. Loughlin, William Lowrance, Paul Maroni, James Mohler, Todd M. MorganRobert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenke, Andrew J. Vickers, Robert Wake, Dorothy A. Shead, Deborah Freedman-Cass

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Abstract

Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.

Original language	English
Pages (from-to)	1534-1561
Number of pages	28
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	13
Issue number	12
DOIs	https://doi.org/10.6004/jnccn.2015.0181
State	Published - Dec 1 2015

Keywords

Biomarkers
Biopsy/methods
Diagnostic Imaging/methods
Early Detection of Cancer/methods
Humans
Male
Mass Screening
Prostatic Neoplasms/diagnosis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.6004/jnccn.2015.0181

Cite this

Carroll, P. R., Parsons, J. K., Andriole, G., Bahnson, R. R., Barocas, D. A., Castle, E. P., Catalona, W. J., Dahl, D. M., Davis, J. W., Epstein, J. I., Etzioni, R. B., Farrington, T., Hemstreet, G. P., Kawachi, M. H., Lange, P. H., Loughlin, K. R., Lowrance, W., Maroni, P., Mohler, J., ... Freedman-Cass, D. (2015). Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 13(12), 1534-1561. https://doi.org/10.6004/jnccn.2015.0181

@article{feb8981c982447c887dd8773b073b553,

title = "Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology",

abstract = "Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.",

keywords = "Biomarkers, Biopsy/methods, Diagnostic Imaging/methods, Early Detection of Cancer/methods, Humans, Male, Mass Screening, Prostatic Neoplasms/diagnosis",

author = "Carroll, {Peter R.} and Parsons, {J. Kellogg} and Gerald Andriole and Bahnson, {Robert R.} and Barocas, {Daniel A.} and Castle, {Erik P.} and Catalona, {William J.} and Dahl, {Douglas M.} and Davis, {John W.} and Epstein, {Jonathan I.} and Etzioni, {Ruth B.} and Thomas Farrington and Hemstreet, {George P.} and Kawachi, {Mark H.} and Lange, {Paul H.} and Loughlin, {Kevin R.} and William Lowrance and Paul Maroni and James Mohler and Morgan, {Todd M.} and Nadler, {Robert B.} and Michael Poch and Chuck Scales and Shaneyfelt, {Terrence M.} and Smaldone, {Marc C.} and Geoffrey Sonn and Preston Sprenke and Vickers, {Andrew J.} and Robert Wake and Shead, {Dorothy A.} and Deborah Freedman-Cass",

year = "2015",

month = dec,

day = "1",

doi = "10.6004/jnccn.2015.0181",

language = "English",

volume = "13",

pages = "1534--1561",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "12",

}

Carroll, PR, Parsons, JK, Andriole, G, Bahnson, RR, Barocas, DA, Castle, EP, Catalona, WJ, Dahl, DM, Davis, JW, Epstein, JI, Etzioni, RB, Farrington, T, Hemstreet, GP, Kawachi, MH, Lange, PH, Loughlin, KR, Lowrance, W, Maroni, P, Mohler, J, Morgan, TM, Nadler, RB, Poch, M, Scales, C, Shaneyfelt, TM, Smaldone, MC, Sonn, G, Sprenke, P, Vickers, AJ, Wake, R, Shead, DA & Freedman-Cass, D 2015, 'Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 13, no. 12, pp. 1534-1561. https://doi.org/10.6004/jnccn.2015.0181

TY - JOUR

T1 - Prostate cancer early detection, version 2.2015

T2 - Clinical practice guidelines in oncology

AU - Carroll, Peter R.

AU - Parsons, J. Kellogg

AU - Andriole, Gerald

AU - Bahnson, Robert R.

AU - Barocas, Daniel A.

AU - Castle, Erik P.

AU - Catalona, William J.

AU - Dahl, Douglas M.

AU - Davis, John W.

AU - Epstein, Jonathan I.

AU - Etzioni, Ruth B.

AU - Farrington, Thomas

AU - Hemstreet, George P.

AU - Kawachi, Mark H.

AU - Lange, Paul H.

AU - Loughlin, Kevin R.

AU - Lowrance, William

AU - Maroni, Paul

AU - Mohler, James

AU - Morgan, Todd M.

AU - Nadler, Robert B.

AU - Poch, Michael

AU - Scales, Chuck

AU - Shaneyfelt, Terrence M.

AU - Smaldone, Marc C.

AU - Sonn, Geoffrey

AU - Sprenke, Preston

AU - Vickers, Andrew J.

AU - Wake, Robert

AU - Shead, Dorothy A.

AU - Freedman-Cass, Deborah

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.

AB - Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.

KW - Biomarkers

KW - Biopsy/methods

KW - Diagnostic Imaging/methods

KW - Early Detection of Cancer/methods

KW - Humans

KW - Male

KW - Mass Screening

KW - Prostatic Neoplasms/diagnosis

UR - http://www.scopus.com/inward/record.url?scp=84983122741&partnerID=8YFLogxK

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000367021100010&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.6004/jnccn.2015.0181

DO - 10.6004/jnccn.2015.0181

M3 - Article

C2 - 26656522

SN - 1540-1405

VL - 13

SP - 1534

EP - 1561

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 12

ER -

Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this